03.07.2007 18:28:00
|
Landec Corporation Schedules Fourth Quarter and Fiscal Year Earnings Release for July 24, 2007 and Conference Call for July 25, 2007
Landec Corporation (Nasdaq:LNDC) announced today that it will report
financial results for the fourth quarter and fiscal year 2007 ended May
27, 2007, after market close on Tuesday, July 24, 2007.
The news release will be followed the next morning, Wednesday, July 25,
2007, by a teleconference and webcast open to all interested parties at
8:00 a.m., Pacific Time. The teleconference can be accessed by calling
866-847-7864 or 703-639-1430. Please log in 5 - 10 minutes prior to the
beginning of the call.
This call is being webcast by Thomson/CCBN and can be accessed at
Landec's web site at www.Landec.com
on the Investor Relations page. The webcast will be available for 30
days through August 24, 2007. A replay of the teleconference will be
available for one week until midnight Eastern Time, Wednesday, August 1,
2007, by calling 888-266-2081 or 703-925-2533. The access code for the
replay is 1111008.
For further information, please call Greg Skinner (650) 261-3677.
The webcast is also being distributed over Thomson/CCBN's Investor
Distribution Network to both institutional and individual investors.
Individual investors can listen to the call through Thomson's individual
investor center at www.fulldisclosure.com
or by visiting any of the investor sites in Thomson's Individual
Investor Network such as America Online's Personal Finance Channel,
Fidelity Investments(R) (Fidelity.com) and others. Institutional
investors can access the call via Thomson's password protected event
management site, StreetEvents (www.streetevents.com).
StreetEvents allows institutional investors to identify, organize, and
track the hundreds of conference calls that occur each day during
earnings season, to download events of interest to their Outlook
calendar, and to RSVP to events online.
Landec Corporation designs, develops, manufactures and sells
temperature-activated and other specialty polymer products for a variety
of food, agricultural and licensed partner applications. The Company's
temperature activated polymer products are based on its patented
Intelimer(R) polymers which differ from other polymers in that they can
be customized to abruptly change their physical characteristics when
heated or cooled through a pre-set temperature switch.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
29.11.24 |
NASDAQ Composite Index-Papier Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor 3 Jahren eingebracht (finanzen.at) | |
22.11.24 |
NASDAQ Composite Index-Papier Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor einem Jahr eingebracht (finanzen.at) | |
21.11.24 |
Gute Stimmung in New York: NASDAQ Composite zum Ende des Donnerstagshandels mit Zuschlägen (finanzen.at) | |
21.11.24 |
Freundlicher Handel: Gewinne im NASDAQ Composite (finanzen.at) | |
21.11.24 |
Anleger in New York halten sich zurück: NASDAQ Composite schwächelt mittags (finanzen.at) | |
21.11.24 |
Börse New York in Rot: NASDAQ Composite beginnt Donnerstagshandel in der Verlustzone (finanzen.at) | |
20.11.24 |
Börse New York in Rot: NASDAQ Composite präsentiert sich zum Handelsende leichter (finanzen.at) | |
20.11.24 |
Handel in New York: NASDAQ Composite verliert am Mittwochnachmittag (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 7,10 | 1,43% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 403,95 | 0,97% |